Thursday, 14 April 2022
  1 Replies
  2.5K Visits

Dear colleagues,

WHO, UNICEF with the support of TechNet-21 invite you to a webinar session on "Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance".

This webinar will orient countries on the new Pfizer BioNTech COVID-19 Vaccine new Tris/Sucrose formulation. The objective is to support countries transition to use the new vaccine formulation, with focus on supply chain and vaccine management, and technical assistance through Third Party Logistics service provider (3PL).

There are two dates, both will offer EN and FR interpretation.

Registration:

EN session (interpretation in FR) - Wednesday, 20 April, 8am UTC: https://who.zoom.us/webinar/register/WN_4QFxLgrzS8ygaAgpy7dbaA 

FR session (interpretation in EN) - Wednesday 20 April, 11.30am UTC: https://who.zoom.us/webinar/register/WN_7Yq3D1jIRaqJ2bmtqjuA5w 

We're looking forward to seeing you joining us. 

The recording, presentation and Q&A of the webinar on ‘Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance’, are now available:

 

IN ENGLISH: 

- Recording: https://youtu.be/B3z0FO_ua3s

- Presentation slides:

- Q&A: https://www.technet-21.org/media/com_resources/trl/7881/multi_upload/FAQ_WebinarTraining_DRAFTv4_techInputs.pdf 

 

EN FRANCAIS:

- Vidéo: https://youtu.be/Vl-VHxo9ytE 

- Présentations:

- FAQ: https://www.technet-21.org/media/com_resources/trl/7901/multi_upload/FAQ_WebinarTraining_DRAFTv4_techInputs_francais.pdf 

  • Page :
  • 1
There are no replies made for this post yet.